Spire Healthcare Group (LSE:SPI) LT-Debt-to-Total-Asset : 0.50 (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Spire Healthcare Group LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Spire Healthcare Group's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.50.

Spire Healthcare Group's long-term debt to total assets ratio increased from Jun. 2023 (0.50) to Jun. 2024 (0.50). It may suggest that Spire Healthcare Group is progressively becoming more dependent on debt to grow their business.

Spire Healthcare Group LT-Debt-to-Total-Asset Historical Data

The historical data trend for Spire Healthcare Group's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spire Healthcare Group LT-Debt-to-Total-Asset Chart

Spire Healthcare Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.48

0.52

0.51

Spire Healthcare Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.50	0.51	0.50	0.51	0.50

Spire Healthcare Group LT-Debt-to-Total-Asset Calculation

Spire Healthcare Group's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	1155.2	/	2288.1
	=	0.50

Spire Healthcare Group's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	1154.2	/	2303.1
	=	0.50

Spire Healthcare Group (LSE:SPI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Spire Healthcare Group LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Spire Healthcare Group's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Spire Healthcare Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Spire Healthcare Group PLC (LSE:SPI) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

SPIl:UK S00:Germany

Address

3 Dorset Rise, London, GBR, EC4Y 8EN

Website

https://www.spirehealthcare.com

Spire Healthcare Group PLC is an independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The Group is a well-located and scalable hospital have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs and Private Medical Insurance providers. It treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.